X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (120) 120
male (92) 92
urology & nephrology (72) 72
female (71) 71
adult (59) 59
middle aged (52) 52
aged (35) 35
risk factors (34) 34
chronic kidney-disease (28) 28
animals (23) 23
kidney failure, chronic - therapy (23) 23
mexico (23) 23
nephrology (21) 21
chronic kidney disease (20) 20
medicine, general & internal (20) 20
rats (20) 20
hemodialysis (18) 18
risk (17) 17
diabetes (16) 16
double-blind method (16) 16
hypertension (16) 16
kidney diseases (16) 16
mortality (16) 16
transplantation (16) 16
young adult (15) 15
disease (14) 14
kidney transplantation (14) 14
treatment outcome (14) 14
glomerular filtration rate (13) 13
kidney (13) 13
prevalence (13) 13
prevention (13) 13
follow-up studies (12) 12
mexico - epidemiology (12) 12
retrospective studies (12) 12
adolescent (11) 11
cardiovascular diseases - prevention & control (11) 11
cross-sectional studies (11) 11
dialysis (11) 11
time factors (11) 11
blood-pressure (10) 10
creatinine - blood (10) 10
diabetes mellitus (10) 10
diabetes mellitus, type 2 - complications (10) 10
epidemiology (10) 10
kidney - metabolism (10) 10
kidney failure, chronic - complications (10) 10
kidneys (10) 10
rats, wistar (10) 10
renal dialysis - adverse effects (10) 10
aged, 80 and over (9) 9
albuminuria (9) 9
blood pressure (9) 9
dialysis patients (9) 9
endocrinology & metabolism (9) 9
immunosuppressive agents - therapeutic use (9) 9
nephropathy (9) 9
renin (9) 9
risk-factors (9) 9
type 2 diabetes (9) 9
abridged index medicus (8) 8
cardiovascular disease (8) 8
cardiovascular diseases - etiology (8) 8
cardiovascular-disease (8) 8
chronic kidney failure (8) 8
cohort studies (8) 8
complications (8) 8
gene-expression (8) 8
hyperparathyroidism, secondary - drug therapy (8) 8
kidney - pathology (8) 8
kidney-disease (8) 8
mesoamerican nephropathy (8) 8
nutrition & dietetics (8) 8
parathyroid-hormone (8) 8
prognosis (8) 8
proportional hazards models (8) 8
renal insufficiency, chronic - etiology (8) 8
stage renal-disease (8) 8
cinacalcet hydrochloride (7) 7
creatinine (7) 7
diet (7) 7
dose-response relationship, drug (7) 7
end-stage renal disease (7) 7
endothelin (7) 7
gene expression (7) 7
glomerular-filtration-rate (7) 7
hemoglobin (7) 7
hyperparathyroidism, secondary - etiology (7) 7
kidney - drug effects (7) 7
kidney - physiology (7) 7
naphthalenes - therapeutic use (7) 7
peripheral vascular disease (7) 7
peritoneal dialysis (7) 7
peritoneal-dialysis (7) 7
public, environmental & occupational health (7) 7
severity of illness index (7) 7
survival (7) 7
analysis of variance (6) 6
biomarkers - blood (6) 6
central-america (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of kidney diseases, ISSN 0272-6386, 2014, Volume 63, Issue 3, pp. 506 - 520
Journal Article
Diabetes, obesity & metabolism, ISSN 1462-8902, 2018, Volume 20, Issue 6, pp. 1369 - 1376
AIMS: Individuals with diabetes and chronic kidney disease (CKD) are at high risk for renal events. Recent trials of novel treatments have been negative,... 
ANTAGONIST | INHIBITION | ALBUMINURIA | PREDICTORS | HEART-FAILURE | MULTIPLE RISK MARKERS | CHRONIC KIDNEY-DISEASE | diabetic kidney disease | endothelin receptor antagonist | randomized controlled clinical trial | atrasentan | personalized medicine | ENDOCRINOLOGY & METABOLISM | Humans | Diabetic Nephropathies - drug therapy | Male | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - drug therapy | Drug Therapy, Combination - adverse effects | Diabetic Nephropathies - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Adult | Endothelin A Receptor Antagonists - adverse effects | Female | Diabetes Mellitus, Type 2 - complications | Drug Resistance | Endothelin A Receptor Antagonists - therapeutic use | Kidney - physiopathology | Precision Medicine | Severity of Illness Index | Kidney - drug effects | Double-Blind Method | Renal Insufficiency, Chronic - physiopathology | Disease Progression | Randomized Controlled Trials as Topic | Kidney Failure, Chronic - prevention & control | Kidney Failure, Chronic - complications | Atrasentan - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Atrasentan - adverse effects | Research Design | Type 2 diabetes | Antimitotic agents | Medical research | Endothelin | Chronic kidney failure | Diabetic nephropathies | Angiotensin | Clinical trials | Albumin | Medicine, Experimental | Antineoplastic agents | Risk factors | Creatinine | Renin | Nephropathy | Kidneys | Diabetes mellitus | Diabetes | Kidney diseases | Diabetes mellitus (non-insulin dependent) | Patients | Clinical Trial Design
Journal Article
by Levin, Adeera and Tonelli, Marcello and Bonventre, Joseph and Coresh, Josef and Donner, Jo-Ann and Fogo, Agnes B and Fox, Caroline S and Gansevoort, Ron T and Heerspink, Hiddo J L and Jardine, Meg and Kasiske, Bertram and Köttgen, Anna and Kretzler, Matthias and Levey, Andrew S and Luyckx, Valerie A and Mehta, Ravindra and Moe, Orson and Obrador, Gregorio and Pannu, Neesh and Parikh, Chirag R and Perkovic, Vlado and Pollock, Carol and Stenvinkel, Peter and Tuttle, Katherine R and Wheeler, David C and Eckardt, Kai-Uwe and Adu, Dwomoa and Agarwal, Sanjay Kumar and Alrukhaimi, Mona and Anders, Hans-Joachim and Ashuntantang, Gloria and Basnet, Shakti and Bello, Aminu K and Chailimpamontree, Worawon and Correa-Rotter, Ricardo and Craig, Jonathan and Douthat, Walter G and Feldman, Harold I and Ganji, Mohammad Reza and Garcia-Garcia, Guillermo and Gharbi, Mohammed Benghanem and Harris, David C and Jha, Vivekanand and Johnson, David W and Kazancioglu, Rumeyza and Langham, Robyn and Liu, Zhi-Hong and Massy, Ziad A and Nangaku, Masaomi and Nelson, Robert G and O'Donoghue, Donal and Okpechi, Ikechi and Pecoits-Filho, Roberto and Powe, Neil R and Remuzzi, Giuseppe and Roberts, Charlotte and Rossert, Jerome and Sola, Laura and Stengel, Benedicte and M, Ernest K. Sumaili and Suzuki, Yusuke and Tanaka, Tetsuhiro and Tatiyanupanwong, Sajja and Thomas, Bernadette and Uhlig, Katrin and Walker, Robert and White, Sarah L and Wiecek, Andrzej and Yang, Chih-Wei and ISN Global Kidney Health Summit participants and ISN Global Kidney Hlth Summit
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 390, Issue 10105, pp. 1888 - 1917
Journal Article
Diabetes, obesity & metabolism, ISSN 1462-8902, 2018, Volume 20, Issue 8, pp. 1829 - 1835
AIM: The SONAR trial uses an enrichment design based on the individual response to the selective endothelin receptor antagonist atrasentan on efficacy (the... 
diabetic kidney disease | endothelin receptor antagonist | precision medicine | randomized controlled clinical trial | atrasentan | KIDNEY-DISEASE | DAPAGLIFLOZIN | ALBUMINURIA | ENDOCRINOLOGY & METABOLISM | DIABETIC-NEPHROPATHY | EMPAGLIFLOZIN | Humans | Middle Aged | Hypertension - drug therapy | Male | Risk | Renal Insufficiency - prevention & control | Renal Insufficiency - epidemiology | Drug Therapy, Combination - adverse effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Diabetic Angiopathies - complications | Endothelin A Receptor Antagonists - adverse effects | Female | Renal Insufficiency - complications | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Drug Resistance | Endothelin A Receptor Antagonists - therapeutic use | Precision Medicine | Double-Blind Method | Diabetic Angiopathies - drug therapy | Antihypertensive Agents - therapeutic use | Diabetic Nephropathies - complications | Atrasentan - therapeutic use | Hypertension - complications | Diuretics - therapeutic use | Aged | Diabetic Nephropathies - epidemiology | Angiotensin Receptor Antagonists - therapeutic use | Atrasentan - adverse effects | Albumin | Endothelin | Kidney diseases | Natriuretic peptides | Creatinine | Brain natriuretic peptide | Kidneys | Sodium | Epidermal growth factor receptors | Diabetes mellitus | Blood pressure | Diabetes mellitus (non-insulin dependent) | Patients | Glomerular filtration rate | Clinical Trial Design
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 26, pp. 2482 - 2494
Journal Article